These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8894785)

  • 1. Additive effect of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis.
    Mantov S; Raev D
    Int J Cardiol; 1996 Oct; 56(2):145-8. PubMed ID: 8894785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Humoral immunity in young hypertension patients].
    Koval' SN; Shuliak LN; Belozerov AP
    Lik Sprava; 1992 Feb; (2):28-30. PubMed ID: 1441324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of serum C3 and essential hypertension].
    Bozzoli C; Muscari A; Puddu GM; Rovinetti C; Renzi C; Vallar G; Puddu P
    G Ital Cardiol; 1992 Dec; 22(12):1361-6. PubMed ID: 1294420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to albumin in the plasma of patients with diabetes mellitus. Relationship with circulating immune complexes.
    Triolo G; Giardina E; Rinaldi A; Seddio G; Bompiani GD
    J Clin Lab Immunol; 1986 Nov; 21(3):113-5. PubMed ID: 3560190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement component 3 (C3) genetics and diabetes mellitus.
    Krantz S; Stelter F; Lober M; Gromoll B
    Biomed Biochim Acta; 1990; 49(12):1237-41. PubMed ID: 2097995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating immune complexes in patients with diabetes type I and II].
    Jabłońska E; Pietruska Z
    Endokrynol Pol; 1993; 44(2):129-35. PubMed ID: 8055783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes, insulin antibodies, and deposits of immunoglobulins in the skin in diabetes.
    Josephsen PG; Permin H; Juhl F; Enk B; Svehag SE
    Dan Med Bull; 1986 Jun; 33(3):171-4. PubMed ID: 3720367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications.
    Ahmed E; Nityanand S; Mustafa A; Brismar K; Lefvert AK
    Clin Exp Immunol; 1999 Feb; 115(2):255-9. PubMed ID: 9933450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of arterial hypertension and type 2 diabetes mellitus with type of polyvascular atherosclerotic disease.
    Dilic M; Dzubur A; Kusljugic Z; Balic S; Pepic E
    Med Arh; 2010; 64(5):264-8. PubMed ID: 21287949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the immunologic profile of newly-diagnosed diabetic patients during the first year of the disease].
    Pizzul MG; Betterle C; De Campo C; Tonini G; Marinoni S; Pocecco M
    Pediatr Med Chir; 1988; 10(5):481-5. PubMed ID: 3071777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levels of various components of the classical and alternative pathways of complement activation in diabetes mellitus patients].
    Titov LP; Korvigo GV; Kharitonik GD; Semenov GV
    Probl Endokrinol (Mosk); 1987; 33(2):9-13. PubMed ID: 3474606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of hyperinsulinemia in the immunopathogenesis of atherosclerosis in diabetics].
    Krasil'nikova EI; Freĭdlin IS
    Patol Fiziol Eksp Ter; 1991; (4):41-3. PubMed ID: 1798652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complement 3 in hypertension and arteriosclerosis].
    Kurochkin GS; Arabidze GG; Liakishev AA; Oshchepkova EV; Gracheva LA; Osipov SG; Titov VN
    Kardiologiia; 1991 Dec; 31(12):28-30. PubMed ID: 1816437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
    Lloyd W; Schur PH
    Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune complexes in diabetes mellitus].
    Kocić R; Radenković S; Milenović M; Mijailović M; Koraćević G; Zivić S; Pesić M; Kosić G
    Srp Arh Celok Lek; 1994; 122 Suppl 1():60-3. PubMed ID: 18173190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathogenic mechanisms in hypertension.
    Lefkos N; Boura P; Boudonas G; Zacharioudaki E; Efthimiadis A; Tsougas M; Epivatianos P
    Am J Hypertens; 1995 Nov; 8(11):1141-5. PubMed ID: 8554739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased atherosclerosis and glomerulonephritis in cynomolgus monkeys (Macaca fascicularis) given injections of BSA over an extended period of time.
    Stills HF; Bullock BC; Clarkson TB
    Am J Pathol; 1983 Nov; 113(2):222-34. PubMed ID: 6227252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes and platelet thromboxane synthesis in patients with insulin-dependent (type I) diabetes mellitus.
    Triolo G; Davi' G; Giardina E; Cardella F; Meli F; La Grutta A; Strano A; Bompiani GD
    Diabetes; 1984 Aug; 33(8):728-31. PubMed ID: 6611280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum C3 and C4 levels and complement-dependent antibody-mediated cytotoxic activity of islet cell surface antibody in type 1 (insulin-dependent) diabetic children.
    Okada S; Sato K; Miyai Y; Masaki Y; Higuchi T; Ogino Y; Ota Z
    Diabetologia; 1987 Nov; 30(11):869-73. PubMed ID: 3328722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.